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OBJECTIVE — We hypothesized that people with type 2 diabetes in an online diabetes
self-management program, compared with usual-care control subjects, would 1) demonstrate
reduced A1C at 6 and 18 months, 2) have fewer symptoms, 3) demonstrate increased exercise,
and 4) have improved self-efﬁcacy and patient activation. In addition, participants randomized
to listserve reinforcement would have better 18-month outcomes than participants receiving no
reinforcement.
RESEARCH DESIGN AND METHODS — A total of 761 participants were randomized
to 1) the program, 2) the program with e-mail reinforcement, or 3) were usual-care control
subjects (no treatment). This sample included 110 American Indians/Alaska Natives (AI/ANs).
Analyses of covariance models were used at the 6- and 18-month follow-up to compare groups.
RESULTS — At 6 months, A1C, patient activation, and self-efﬁcacy were improved for pro-
gram participants compared with usual care control subjects (P  0.05). There were no changes
in other health or behavioral indicators. The AI/AN program participants demonstrated im-
provements in health distress and activity limitation compared with usual-care control subjects.
ThesubgroupwithinitialA1C7%demonstratedstrongerimprovementinA1C(P0.01).At
18months,self-efﬁcacyandpatientactivationwereimprovedforprogramparticipants.A1Cwas
not measured. Reinforcement showed no improvement.
CONCLUSIONS — An online diabetes self-management program is acceptable for people
withtype2diabetes.Althoughtheresultsweremixedtheysuggest1)thattheprogrammayhave
beneﬁcial effects in reducing A1C, 2) AI/AN populations can be engaged in and beneﬁt from
online interventions, and 3) our follow-up reinforcement appeared to have no value.
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T
ype 2 diabetes affects 9.6% of the
adult population, and its prevalence
is increasing (1). While the need for
self-management support is well docu-
mented, most diabetes education studies
have taken place in clinical settings and
targetedthosewhohaveahighA1C(usu-
ally 7%). Recent community-level,
peer-led, small-group diabetes self-
management programs have shown
promise (2,3). However, not all patients
with type 2 diabetes are willing or able to
participate in small-group programs, nor
aresuchprogramslikelytobeavailablein
all locations.
There are few studies of community-
based diabetes education programs for
American Indians/Alaskan Natives (AI/
ANs). We report on a randomized, con-
trolled trial of an Internet-based diabetes
self-management program (IDSMP) in-
cluding AI/ANs. This was the ﬁrst study,
to our knowledge, examining such a pro-
gram among AI/ANs.
The Cochrane Collaboration re-
viewed group-based training for type 2
diabetes (4). They found 11 studies that
met their criteria. Eight of these were ran-
domized studies and three were con-
trolled studies. All of the interventions
were taught by health professionals. One
study took place in a community setting,
and one reported a mean baseline A1C
7%.
Jacksan et al. (5) conducted a system-
atic review of computer-assisted technol-
ogies in diabetes prior to 2004. They
found four articles involving patient edu-
cation. In an early study, (6) groups were
randomized to basic diabetes informa-
tion, tailored online coaching, or peer
support. Improvement in health behav-
iors and psychological outcome were
found in all three groups, with no differ-
ences between groups. Glasgow et al. (7)
showed that a computer-assisted inter-
vention was practicable and acceptable in
a real-world setting and resulted in im-
provements in recommended services. In
a low-intensity computer program study,
short-term outcomes were promising but
not signiﬁcant (8). Wengberg (9), utiliz-
ing an computer diabetes intervention,
has suggested that self-efﬁcacy may func-
tion as a moderator for diabetes behavior
change, and Gerber et al. (10) have dem-
onstratedusabilityofanInternetprogram
for young inner-city adults. In summary,
Internet-based educational programs
havebeendemonstratedtochangebehav-
iors and sometimes health status. We
wereunabletoﬁndcomputer-basedstud-
ies demonstrating changes in A1C.
RESEARCH DESIGN AND
METHODS— We report on a ran-
domized 6-month trial of the IDSMP,
withan18-monthfollow-up.Wehypoth-
esized that participants in the IDSMP,
compared with usual-care control sub-
jects, would demonstrate 1) reduced A1C
at 6 and 18 months, 2) have fewer symp-
toms, 3) have increased exercise, and 4)
have improved self-efﬁcacy and patient
activation.Wealsohypothesizedthatpar-
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serve, peer-support group would have
better 18-month outcomes than partici-
pants receiving no follow-up.
The IDSMP
The asynchronous, 6-week, IDSMP is
based on English- and Spanish-language
peer-led small-group diabetes self-
management programs (2,3). The IDSMP
consists of six weekly sessions. Partici-
pants logged on individually to the ses-
sions, which were available for the entire
week. The topics covered are shown in
online appendix Table A1 (available in
the online appendix at http://care.
diabetesjournals.org/cgi/content/full/dc09-
2153/DC1).
A password-protected homepage
provides access to the weekly activities,
includingTheLearningCenter,wherethe
program content is offered in 20–30 new
Web pages weekly. Each week, partici-
pantsareaskedtoreplytoaquestionsuch
as “What problems do you have because
of your diabetes?” and to make a speciﬁc
action plan. The questions and action
plans are posted on bulletin boards in the
Discussion Center, where they can be
seen by all participants.
The Discussion Center is made up of
four interactive threaded bulletin boards
(Action Planning, Problem Solving, Difﬁ-
cult Emotions, and Celebrations) popu-
lated by responses made in the Learning
Center, as well as new threads started by
participants whenever they wish. A typi-
cal program of 20–25 participants results
in500ormoreposts.MyToolsconsistsof
exerciseandmedicationlogs,audiorelax-
ation exercises, meal planning, and glu-
cose-monitoring tools and links to other
diabetes-relatedWebsites.PostOfﬁceisa
sectionwhereparticipantsandfacilitators
can write private, individual messages to
each other. Help is a section where par-
ticipants can e-mail the moderators or
program administrators. The latter is also
available via a toll-free telephone line.
InadditiontotheWebprogram,each
participant received a copy of the book,
Living a Healthy Life with Chronic Condi-
tions (11). Speciﬁc sections of this book
are referenced in the Learning Center.
The book is used as a reference not as a
text. Thus, the program consists of the
online interactive training plus the book.
Facilitators
Two peers facilitate each program. Facil-
itators were previously trained as self-
management small-group leaders and
had taken the IDSMP (as nonstudy sub-
jects). Facilitators assist participants by
reminding them to log on, modeling ac-
tionplanningandproblem-solving,offer-
ing encouragement, and posting to the
bulletin boards. They also monitor the
daily posts for safety and report inappro-
priate posts to the investigators. All facil-
itationtakesplaceonline,mainlyviaposts
within the program pages. Each partici-
pant receives personalized responses
from facilitators during each weekly ses-
sion.Unlikethesmall-groupprogram,fa-
cilitators do not deliver content, as this is
scriptedintheLearningCenter.Programs
were facilitated by 16 different people,
half with diabetes. Each program has at
least one facilitator with diabetes. The
study was approved by the Stanford
School of Medicine Institutional Review
Board.
Participants and data collection
Participants were aged 18 years, were
not pregnant or in care for cancer, had
physician-veriﬁed type 2 diabetes, and
had access to the Internet. Recruitment
was largely via the Internet, although
print and broadcast media were also uti-
lized. Special effort was made to recruit
AI/AN participants using Web sites and
media associated with tribal and AI/AN
organizations. This was accomplished
utilizing the expertise of an AI/AN re-
searcher (12).
All consents and questionnaires were
administered online. Participants con-
tacted the study by going to the Web site,
where they were screened for eligibility
and were asked to complete consent and
baseline questionnaires. A1C was ob-
tained using mailed self-administered
BIOSAFE kits (13).
After returning A1C kits, participants
were randomized using a random-
numbers table. Roughly two-thirds be-
came treatment subjects and one-third
continuedwithusualcare(noprogramor
other treatment offered). Treatment sub-
jectswerefurtherrandomizedoneforone
to receive follow-up reinforcement
(membership in a listserve discussion
group) or no reinforcement. Usual care
consisted of whatever care participants
hadbeenpreviouslyreceivingandranged
from community clinics to specialist care.
Usual-care participants were not re-
stricted from seeking additional care or
programs. All participants received a $10
Amazon.com certiﬁcate after completing
each questionnaire and returning their
A1C sample.
Randomized study
The randomized IDSMP group was com-
paredwiththeusual-carecontrolgroupat
6 months. If the reinforcement study (be-
low) had shown that reinforcement par-
ticipants had greater improvements than
unreinforcedIDSMPparticipants,thetwo
IDSMP groups would be compared with
control participants separately. If there
werefewdifferences,thetworandomized
IDSMP groups would be combined and
compared with the usual-care control
group.
After 6 months, usual-care partici-
pants recruited as part of the AI/AN sub-
groupwereofferedtheprogram.Allother
usual-care participants continued as con-
trolsubjectsthroughthe18monthsofthe
study. Follow-up data collected at 18
months allowed comparison of IDSMP
participants to usual-care subjects, ex-
cluding the AI/AN subset.
Reinforcement study
The reinforcement study compared
IDSMP treatment participants who had
no reinforcement with those who had
been randomized to a listserve discussion
group. The discussion group was in-
tended to reinforce any beneﬁts of the
program by providing peer support.
Comparisons were made at 6 and at 18
months. The AI/AN participants were in-
cluded in the 18-month reinforcement
study.
AI/AN study
AI/AN participants were randomized
with other participants but entered the
randomized study for only 6 months, af-
ter which time AI/AN usual-care partici-
pants were offered an opportunity to take
the IDSMP. The lack of adequate usual
medical care and chronic health dispari-
ties among the AI/AN subset, as well as
the longstanding mistrust of research in
many AI/AN communities, were reasons
the AI/AN subset was randomized using
the waitlist control design. A pilot study
of 27 AI/AN and 27 non-AI/AN partici-
pants with diabetes had conﬁrmed the
feasibility of the online programs for this
population (14).
Health status, health behaviors,
health care utilization, patient activation,
and self-efﬁcacy were measured at each
time point. The speciﬁc measures were
based on diabetes-related problems iden-
tiﬁed in participant focus groups and on
self-efﬁcacytheory(15).Theprimaryout-
come measure was A1C, measured using
capillary blood obtained with self-
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anexpectednondiabeticrangeof3.8–5.9
compared with 4–6 for National Glyco-
hemoglobin Standardization Program
standards (16). A paired duplicate speci-
men comparison with the whole-blood
method at Stanford Hospital Laboratories
showed excellent correlation and preci-
sion. These assays have independently
been shown to be reliable and valid (16).
The A1C measure was not available for
the 18-month comparisons because BIO-
SAFE ceased operation early in the 18-
month data collection. Health-related
distress was measured by the health dis-
tressscale,adaptedfromtheMedicalOut-
come Study (17). The activity limitations
scale, which measures the impact of dis-
ease on role activities such as recreation
and chores, was developed for an earlier
study (18). Depression was measured by
the Patient Health Questionaire (PHQ)-9
(19). A physical activities scale measured
totalminutesperweekofaerobicexercise
(18).
Tertiary measures included the 13-
item short-form Patient Activation Mea-
sure (PAM) and diabetes self-efﬁcacy.
PAM measures patient self-reported
knowledge, skill, and conﬁdence for
managing their chronic condition (20).
The diabetes self-efﬁcacy scale was devel-
oped for a small-group diabetes program
(2) and based on earlier chronic-disease
self-efﬁcacy scales (18).
Health care utilization over the prior
6 months was measured by self-report. In
a study comparing the validity of self-
reportedwithchartaudit(21),therewere
nobiasestowardimprovedreportingover
time. Details of the psychometric proper-
tiesformostofthemeasurescanbefound
at http://patienteducation.stanford.edu/
research.
Data analysis
Baseline randomization. T tests were
used to compare baseline IDSMP partici-
pants with usual-care participants and to
compare baseline reinforced with unrein-
forced IDSMP participants. We included
all variables demonstrating signiﬁcant
differences at baseline as covariates in
subsequent multivariate analyses at 6 and
18 months.
Noncompleters. Totestthepotentialef-
fect of dropouts, we compared the base-
line variables for those who failed to
complete the 6-month questionnaires
with those who had completed question-
naires, utilizing t tests. Control versus
treatment noncompleters were then
compared.
Reinforcement. ANCOVA models were
used to compare reinforced with unrein-
forced program participants. Six- and 18-
month outcomes were the dependent
variables with demographic variables and
the outcome variable at baseline included
as covariates. Least-square means (com-
puted as part of the ANCOVA procedure
and adjusted for covariates) were used to
determine if there were signiﬁcant differ-
ences between the treatment groups ran-
domized to reinforcement and no
reinforcement.
Six-month outcomes. ANCOVA mod-
elscomparedprogramandcontrolpartic-
ipants at 6 months. As reinforcement
proved to have no effect on the outcomes
(see results below), reinforced and unre-
inforced participants were combined to
create one treatment group, which was
then compared with the control partici-
pants. Separate comparisons of the
control subjects and reinforced and unre-
inforced program participants are also
presented. All subjects, irrespective of the
number of weeks they participated in the
intervention, were included in the analy-
ses. Least-square means (adjusted for co-
variates) were used to determine if there
were signiﬁcant differences between the
programparticipantsandtherandomized
usual-care control group after controlling
for baseline outcome values and demo-
graphic covariates.
ANCOVA models were repeated,
adding interaction terms of all baseline
outcome variables with randomization.
Thiswastoascertainifexistingconditions
might moderate the effectiveness of the
program and help determine the charac-
teristicsofparticipantsmostlikelytoben-
eﬁt.Analysesweredoneusingbothactual
data collected and intent-to-treat meth-
odology, based on substituting last ac-
quireddataformissingdata.Inthecaseof
6-month outcomes, this resulted in the
assumption of no change from baseline. P
values are interpreted within each cate-
gory of outcome (A1C, three health indi-
cators, one health behavior, self-efﬁcacy,
patient activation, and utilization).
Eighteen-month outcomes. Random-
ized program participants were com-
pared to the usual-care control group at
18 months, using the methodology
(ANCOVA) discussed above.
Subgroupanalyses. Six-monthanalyses
(ANCOVA models) comparing random-
ized treatment participants and usual-
care control subjects were then done for
two subsets of the original study sample:
AI/ANs and participants with baseline
A1C 7%.
RESULTS
Participation
Approximately36%ofparticipantsfound
theWebsitethroughlinksontheInternet
or search engines. Another 21% learned
of the study via e-mail or e-mail newslet-
ters; 9% were referred by relatives,
friends, or coworkers; 17% were referred
through print media; and 10% were re-
ferred by health professionals. The AI/AN
subset discovered the study through the
Web (29%, including 5% who found out
about the study via tribal Web sites) and
e-mail (20%). Larger numbers were re-
ferred by relatives or acquaintances
(21%), and 18% found the study through
print media (including 15% via AI/AN-
oriented media).
A total of 1,463 people visited the
Websiteandleftcontactinformation(on-
line appendix Fig. A1). Of these, 1,019
completedenrollmentscreeningandpro-
ceeded to the baseline questionnaire. A
further 48 were disqualiﬁed, 22 subse-
quently declined, 74 failed to complete
consent or baseline questionnaires, and
104 failed to complete A1C testing. The
remaining 761 participants completed
baseline assessments and were random-
ized to one of three groups: usual-care
control group (270), the online program
(259), or the online program plus list-
serve e-mail reinforcement (232). Subse-
quently,27withdrewordroppedoutand
2 died before completing the 6-month
questionnaire. Thus, 732 continued in
the study for 6 months. Of those continu-
ing, 645 (85%) completed the 6-month
questionnaire. These included 238 con-
trol subjects and 395 participants in the
online program (109 unreinforced treat-
ments and 186 reinforced treatments).
Between August 2006 and September
2007,21programswereheldwithamean
of 23 participants per program.
The AI/AN recruitment resulted in a
sample that included 110 AI/AN partici-
pants. (see online appendix Fig. A2). Af-
ter6months,AI/ANcontrolsubjectswere
allowed to enroll in the program and thus
were no longer part of the randomized
study. Of 651 remaining (non-AI/AN)
study participants, 528 (81%) completed
18-month questionnaires.
Lorig and Associates
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Study participants were predominantly
non-Hispanic white (76%), female
(73%),married(66%),andwelleducated
(mean of 15.7 years of education). The
average age was 54.3 years. The only sta-
tistical difference between the random-
ized treatment and control groups was
percentage married (78 vs. 71%, P 
0.034; online appendix Table A2). Per-
centage married, as well as other demo-
graphic variables, were included as
covariates in subsequent ANCOVA. The
control subjects had slightly higher PHQ
depression levels at baseline (Table A3).
The mean baseline A1C level at baseline
was6.44%,relativelylowforapopulation
with diabetes.
The AI/AN subset represented 70
tribal groups. They were slightly younger
than the non-AI/AN participants (mean
age 51 vs. 55 years, P  0.001) and were
less likely to be married (57 vs. 68%, P 
0.035). Demographics for AI/ANs by ran-
domization are given in Appendix Table
A2. The AI/AN subset also had higher
baseline mean A1C (6.9 vs. 6.4, P 
0.001). None of the other outcome vari-
ables differed signiﬁcantly from non-AI/
ANs at baseline.
Program usage
Case et al. (22) conducted a study of the
IDSMP utilization by 45 participants (15
each African American, Non-Hispanic
white, and AI/ANs). The median number
of days for writing messages for all races
was 32 (30 for African Americans, 37 for
Non-Hispanic whites, and 28 for AI/
ANs), with 80% of participants writing
messages over a period of at least 21 days
or half the length of the workshop. The
median number of messages per partici-
pant was 17 and the mean was 25. There
were few differences among the racial
groups, although AI/ANs logged for a
shorter time period than non-Hispanic
whites. There were few differences in the
content of the posts.
Six-month noncompleters
There were few signiﬁcant differences at
baseline between those who completed
6-month questionnaires and those who
did not. Noncompleters were younger,
less likely to be married, and less likely to
be non-Hispanic white. They had higher
mean baseline A1C and higher levels of
health distress. However, there were no
signiﬁcantdifferencesbetweenthepartic-
ipant noncompleters and the usual-care
controlnoncompleters(seeonlineappen-
dix Table A4).
Six-month randomized outcomes
Table 1 provides information regarding
the changes in outcome variables for the
control and treatment participants. Be-
cause reinforcement was not associated
with any improvements (see below under
REINFORCEMENT STUDY), the two treatment
groups were combined for the 6-month
comparison to usual-care control sub-
jects, as well as kept separate. Treatment
participants, when compared with usual-
care control subjects, had signiﬁcantly
lower A1C (P  0.05) as well as improve-
ments in patient activation (PAM) and
self-efﬁcacy (0.021 and 0.001, respec-
tively). Health behavior and utilization
changes were not signiﬁcantly different
for treatment compared with control
group participants. When intent-to-treat
analyseswereused,PAMandself-efﬁcacy
remainedsigniﬁcant,whilethePvaluefor
A1C increased to 0.060.
When ANCOVAs were rerun with
baseline randomization interaction terms
included in the models, the interaction of
A1C with randomization was signiﬁcant
in predicting 6-month A1C (P  0.001).
AI/AN versus non-AI/AN interactions
with randomization were signiﬁcant in
predicting 6-month health distress, activ-
ity limitation, and physician visits. These
two initial conditions were then exam-
ined in more detail below. Baseline self-
efﬁcacy also had signiﬁcant interactions
with randomization and appears to be a
moderating variable, suggesting that
lowerbaselineself-efﬁcacywasassociated
with better outcomes. This will be exam-
ined elsewhere.
Eighteen-month randomized
outcomes
The comparison of 18-month completers
to noncompleters showed few differ-
ences: the noncompleters were younger,
had higher A1C, and higher health dis-
tress at baseline (online appendix Table
A8).Therewerenosigniﬁcantdifferences
between the participant and usual-care
control noncompleters. We could not in-
clude A1C analyses at 18 months because
of the closure of the laboratory. Results
fromasecondlaboratorycouldnotbead-
equately correlated with the original lab.
Of the remaining outcome variables, two
had signiﬁcantly greater improvements
for program participants as compared
with the usual-care participants: self-
efﬁcacy to manage diabetes and PAM pa-
tient activation (P  0.016, 0.007,
respectively; online appendix Table A6).
Other 18-month change score differences
werenotsigniﬁcant.Intent-to-treatmeth-
odology resulted in the P value for PAM
increasing to 0.052.
Reinforcement study
Online appendix Fig. A3 gives informa-
tion about the participants in the rein-
forcement study. At 6 months, there was
only one signiﬁcant difference between
reinforced (n  186) and unreinforced
(n  209) participants. The unreinforced
participants had greater improvement in
health distress (P  0.007; online appen-
dix Table A7). At 18 months, there again
wasonevariablethatwassigniﬁcantlydif-
ferent. The unreinforced participants had
a greater reduction in depression (P 
0.033;onlineappendixTableA8).Intent-
to-treat methodology did not change the
results.
High A1C subgroup
When only participants with baseline
A1C 7.0% are included at 6 months
(online appendix Table A9), the differ-
ence between treatment and control for
A1C was 0.614 (P  0.010, effect size
0.499). Self-efﬁcacy was also statistically
signiﬁcant (P  0.040), although the ef-
fect size was small.
AI/AN subgroup
At 6 months, the AI/AN subsample was
underpowered (n  73). Despite the low
number of cases, there were signiﬁcant
decreases in health distress and activity
limitationforAI/ANprogramparticipants
comparedwithcontrolsubjects(Table2).
Whilenotstatisticallysigniﬁcant,theA1C
change score difference between the two
groups was nearly 0.3. The treatment
group had a statistically signiﬁcant in-
creaseinphysicianvisits.Usingintent-to-
treat methodology, activity limitation
remained signiﬁcant, while health dis-
tress and physician visits became mar-
ginal. Tables A10 and A11 in the online
appendix present the 6-month data for
AI/ANs and non-AI/ANs separately.
CONCLUSIONS — At 6 months, re-
sults were mixed. The changes in the pri-
mary outcome variable (A1C) had a small
(effect size  0.111) but statistically sig-
niﬁcantdifferencebetweentreatmentand
usual-care control groups when only
looking at actual cases (P  0.039). The
two tertiary outcomes, patient activation
and self-efﬁcacy, both improved for treat-
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care control subejects. However
secondary outcomes did not improve.
None of the three health indicators
showed signiﬁcant differences, nor were
the amount of exercise or number of phy-
sician visits signiﬁcantly changed. At 18
months, PAM patient activation and self-
efﬁcacy were signiﬁcantly increased for
program participants, although PAM be-
came marginal when intent-to-treat
methodology was used. Other outcomes
variables were not signiﬁcant at 18
months. Randomization to listserve
e-mail peer-support reinforcement did
not improve the outcomes for program
participants, either at 6 or 18 months.
Surprisingly the attempt at reinforce-
mentwasnoteffective.Weencountereda
similar ﬁnding in another study, using a
different reinforcement technique (auto-
matedfollow-upphonecalls)(3).Further
study, including more attention to how
the listserve was utilized, would be re-
quired to determine if only our particular
attempts at reinforcement were unsuc-
cessful or if follow-up in general is not
called for with similar self-management
programs. In addition, further study of
programﬁdelityandhowprogrampartic-
ipants utilized the program, including
any possible dose effect, would be desir-
able. The lack of a detailed analysis of ef-
fects of program utilization, as well as
analyses of possible mediating effects of
secondary and tertiary variables, is an im-
portant limitation but was beyond the
scope of this study.
A further limitation of the study was
therelativelylowmeanA1Catbaseline.A
large portion of the participants were in
control and more likely to get worse
ratherthanbetterduetobothaﬂooreffect
and regression to the mean. When we
looked at the subgroups of those with
baseline A1C 7.0% at baseline, the dif-
ferences in improvements in A1C in-
creased from a very modest effect size of
0.11 for the entire randomized sample to
a clinically signiﬁcant effect size of 0.50.
Thissuggeststhattheprogrammayprove
more successful if targeted to patients
with higher A1C.
When we limited ourselves to the
AI/AN subset (who had a mean baseline
A1C of nearly 7.0% compared with the
total sample mean of 6.4%), we saw im-
provements in health indicators (activity
limitationsandhealthdistresswithsignif-
icant effect sizes of 0.48 and 0.34, respec-
tively). Although the difference for A1C
was not statistically signiﬁcant, with a
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difference of 0.25 would undoubtedly
have been statistically signiﬁcant.
The methods of recruitment and de-
sign of the study may have contributed to
low differences between treatment and
controlparticipants.Ahighproportionof
those who joined the study were actively
seeking information about their disease
when they found the study Web site. The
control group was not offered the possi-
bility of participation in the program after
a short period of time and may have
searched for and found alternate inter-
ventions.TheAI/ANsubgroupwasanex-
ceptioninthisregardastheywereoffered
the program after 6 months. This may
have contributed to the relative success of
the program within that subgroup.
Althoughresultswerebothencourag-
ing and discouraging, they suggest that
the program can be beneﬁcial to people
with diabetes and that further study is
warranted. A trial with broader recruit-
ment, limited to only those with A1C
7.0%, and allowing randomized con-
trol subjects to participate in the program
after a 6-month trial would prove more
deﬁnitive.
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